Funded Tech Companies
ApoVax
ApoVax, based in Louisville, received equity investments through Kentucky Seed Capital Fund and private investors.
Company Overview
Company Name
ApoVax
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1044 East Chestnut St.
Louisville, KY 40204
USA
Louisville, KY 40204
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville. ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Lynch
Chief Operating Officer
Patricia Beckmann
Chief Scientific Officer
Haval Shirwan
VP - Bus. Development
Andrew Steen
VP - R & D
Kathryn MacLeod
Company Investors
- Kentucky Seed Capital Fund (Steve Gailar)
- Kentucky Seed Capital Fund (George Emont)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs